-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
CCL Products (India) Ltd Tea
- Indian Private
- BSE Code : 4907.0
- ISIN : INE421D01022
-
Today’s Low
1,196.10 -
Today’s High
1,213.70
-
Open
1,204.30 -
Perv Close
1,205.20 -
52W Low
815.50 -
52W High
1,242.20
Key Indicators
-
P/E(TTM)
55.94
-
Mar.Cap (₹Cr.)
16,066.08
-
Div & Yield %
0.48
-
Book Value(₹)
103.13
-
Debt-Equity Ratio
-0.17
-
AGM Date
22-Jul-2026
-
EPS
21.51
-
P/E Ratio
55.94
Financials Ratios
-
Debt-Equity Ratio
0.80
-
Mar.Cap (₹Cr.)
16,066.08
-
RONW (%)
15.77
-
ROCE (%)
12.38
Score Board
-
Equity (₹ in Cr.)
26.71
-
BV (₹)
103.10
-
Sales( ₹ in Cr.)
2,216.05
-
NP (in Cr.)
287.19
-
NP Var(%)
211.0
-
Div%
288.0
-
CPS (₹)
25.70
-
EPS (₹)
21.50
-
Traded Value (₹ in Lakhs)
16,066.08
-
52 Week High
1,242.20
-
52 Week Low
815.50
-
Price BSE
1203.0
-
Price NSE
1,203.00
-
Market Capital( in Cr.)
16,066.08
-
P/C Ratio
46.80
-
P/E Ratio
55.90
-
Price Vs.BV
21.50
-
21-Jul-2026( 06:39)
Corporate News - CCL P... - CCL Products (India) has allot...
-
17-Jul-2026( 10:19)
Corporate News - CCL P... - CCL Products (India) will hold...
-
13-Jul-2026( 07:09)
Corporate News - CCL P... - CCL Products (India) has allot...
-
08-Jun-2026( 02:30)
Hot Pursuit - Volum... - <p>Pfizer Ltd, Syngene Interna...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,718.00 | 1,456.17 | 1,356.13 | 922.94 | 795.07 | 822.65 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,718.00 | 1,456.17 | 1,356.13 | 922.94 | 795.07 | 822.65 |
| Other Income | 13.91 | 5.60 | 40.58 | 31.28 | 66.50 | 133.94 |
| Stock Adjustments | -15.38 | 35.28 | 0.63 | 54.89 | -13.19 | 29.27 |
| Total Income | 1,716.53 | 1,497.05 | 1,397.34 | 1,009.11 | 848.38 | 985.86 |
| EXPENDITURE : | ||||||
| Raw Materials | 957.33 | 787.25 | 733.36 | 496.92 | 344.20 | 418.10 |
| Power and Fuel Cost | 90.65 | 105.55 | 98.03 | 62.32 | 42.91 | 54.28 |
| Employee Cost | 112.52 | 100.79 | 79.33 | 43.19 | 38.01 | 34.23 |
| Other Manufacturing Expenses | 165.92 | 185.71 | 123.58 | 101.18 | 101.48 | 78.38 |
| Selling and Administration Expenses | 163.23 | 109.56 | 106.84 | 79.78 | 66.21 | 61.94 |
| Miscellaneous Expenses | -21.08 | -8.99 | -3.05 | -2.55 | 2.42 | -1.74 |
| Employee Benefit Expenses | 112.52 | 100.79 | 79.33 | 43.19 | 38.01 | 34.23 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,468.56 | 1,279.88 | 1,138.09 | 780.85 | 595.22 | 645.19 |
| Operating Profit | 247.96 | 217.16 | 259.25 | 228.26 | 253.16 | 340.67 |
| Interest | 68.81 | 45.18 | 26.59 | 13.80 | 15.72 | 16.91 |
| Gross Profit | 179.15 | 171.98 | 232.66 | 214.46 | 237.44 | 323.76 |
| Depreciation | 48.70 | 51.81 | 36.39 | 30.77 | 27.02 | 25.43 |
| Profit Before Tax | 130.45 | 120.17 | 196.27 | 183.69 | 210.42 | 298.33 |
| Current Tax | 29.35 | 20.94 | 34.47 | 38.69 | 48.97 | 52.22 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 8.81 | 3.93 | -13.56 | 17.80 | 2.76 | 7.18 |
| Reported Net Profit | 92.30 | 95.31 | 175.36 | 127.20 | 158.69 | 238.93 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 |
| Adjusted Net Profit | 92.30 | 95.31 | 175.36 | 127.20 | 158.69 | 238.97 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 783.83 | 755.04 | 646.19 | 619.92 | 487.83 | 338.70 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 26.71 | 66.51 | 66.51 | 66.51 | 26.61 | 89.79 |
| P & L Balance carried down | 849.43 | 783.83 | 755.04 | 680.60 | 619.92 | 487.83 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 250.00 | 225.00 | 275.00 | 250.00 | 200.00 | 250.00 |
| Dividend Per Share(Rs) | 5.00 | 4.50 | 5.50 | 5.00 | 4.00 | 5.00 |
| Earnings Per Share-Unit Curr | 6.91 | 7.16 | 13.18 | 9.56 | 11.93 | 17.96 |
| Earnings Per Share(Adj)-Unit Curr | 6.91 | 7.16 | 13.18 | 9.56 | 11.93 | 17.96 |
| Book Value | 89.01 | 83.75 | 81.09 | 74.67 | 69.79 | 59.57 |
| Book Value(Adj)-Unit Curr | 89.01 | 83.75 | 81.09 | 74.67 | 69.79 | 59.57 |
